Abstract 245: Interleukin-4 receptor-targeted Abraxane inhibits tumor growth by enhancing drug delivery and reprogramming of M2-type macrophages into M1 phenotype
Authors:
Open Access
- 15 June 2022
- journal article
- poster presentations---proffered-abstracts
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 245